Purple Biotech
PPBT
15 hedge funds and large institutions have $1.86M invested in Purple Biotech in 2020 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 19 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
48% less funds holding
Funds holding: 29 → 15 (-14)
66% less capital invested
Capital invested by funds: $5.52M → $1.86M (-$3.66M)
74% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
+$178K |
| 2 |
Goldman Sachs
New York
|
+$70.4K |
| 3 |
Morgan Stanley
New York
|
+$37.1K |
| 4 |
ECM
ETrade Capital Management
Arlington,
Virginia
|
+$32.1K |
| 5 |
NSIM
North Star Investment Management
Chicago,
Illinois
|
+$2.47K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$400K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$281K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$161K |
| 4 |
VF
Virtu Financial
New York
|
-$119K |
| 5 |
JMPWA
JP Morgan Private Wealth Advisors
San Francisco,
California
|
-$56K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RG
26
Rikoon Group
Santa Fe,
New Mexico
| – | -$17K | -8 | Closed |
|
27
Creative Planning
Overland Park,
Kansas
| – | -$14K | -7 | Closed |
|
28
HighTower Advisors
Chicago,
Illinois
| – | -$12K | -6 | Closed |
|
29
Commonwealth Equity Services
Waltham,
Massachusetts
| – | -$11K | -5 | Closed |
|
|
PAG
30
Private Advisor Group
Morristown,
New Jersey
| – | -$3K | -2 | Closed |
|
|
SFS
31
Sowell Financial Services
North Little Rock,
Arkansas
| – | -$4K | -2 | Closed |
|
|
APWA
32
Atlas Private Wealth Advisors
Matawan,
New Jersey
| – | -$2K | -1 | Closed |
|
|
JCM
33
Jacobi Capital Management
Pittston,
Pennsylvania
| – | -$2K | -1 | Closed |
|
34
Wells Fargo
San Francisco,
California
| – | -$1K | – | – |
|
PPBT Hedge Fund Activity: Q3 2020 in Review
15 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Purple Biotech (PPBT) for Q3 2020, worth a combined $1.86M — down 66% from $5.52M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of PPBT and 5 opened new positions — a net loss of 14 holders — while 3 trimmed existing stakes and 2 added.
The largest buyer was Susquehanna Fundamental Investments, opening a new position worth an estimated $178K. The largest seller was Citadel Advisors, exiting entirely with an estimated $400K sold.
- 15 institutional investors held Purple Biotech (PPBT) as of Q3 2020, down from 29 in Q2 2020.
- Funds reported $1.86M of Purple Biotech stock for Q3 2020, down 66% quarter-over-quarter.
- 5 funds opened new Purple Biotech positions in Q3 2020 and 19 closed out, a net change of -14 holders.
- The largest Purple Biotech buyer in Q3 2020 was Susquehanna Fundamental Investments, an estimated $178K added.
- The largest Purple Biotech seller in Q3 2020 was Citadel Advisors, an estimated $400K sold.
Based on aggregated 13F filings for Q3 2020.